Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Mar 11 2026

Full Issue

Study: New Blood Test May Forecast Women's Dementia Risk 25 Years Early

Researchers looked at levels of p-tau217 among women with no signs of cognitive issues and found that those with higher levels were "much more likely" to develop dementia. Also: Psilocybin might be better at helping smokers quit than nicotine patches, researchers say.

Fox News: Blood Test May Predict Women’s Dementia Risk Up To 25 Years Early, Study Finds

A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge. That’s according to new research from the University of California San Diego, which found that a specific biomarker protein associated with early pathological processes of Alzheimer’s disease was "strongly linked" to future dementia risk. (Rudy, 3/10)

MedPage Today: High-Dose Psychedelic Beats Nicotine Patches For Smoking Cessation

A single high-strength dose of psilocybin was more effective than nicotine patches for helping smokers quit, a pilot randomized trial showed. (Monaco, 3/10)

CIDRAP: Public Health Alerts: Tobacco Use Among US Adults, 2023-2024

A Public Health Alerts report today notes that cigarette smoking in US adults dropped from 10.8% in 2023 to 9.9% in 2024, while the use of other tobacco products, such as cigars and e-cigarettes, stayed flat, and 18.8% of US adults—or about 48 million—used at least one tobacco product in 2024. Public Health Alerts, a new collaboration between NEJM Evidence and CIDRAP, fills a gap in reliable data, offering expert-reviewed reports that translate frontline observations into actionable public health evidence. An NEJM Evidence editorial explains the initiative further. (Wappes, 3/10)

The 19th: How Your Favorite Influencer’s Food Content Could Be Fueling Eating Disorders

In 2013, when Kate Regan was a senior in high school, she became fixated on health and nutrition. She found content from online creators who made “what I eat in a day” videos inspiring. What she didn’t realize at the time was that this curiosity was masking a developing eating disorder. (Lyons, 3/10)

NBC News: Oysters And Clams In 9 States Could Be Contaminated With Norovirus, FDA Warns

The Food and Drug Administration warned consumers Monday about oysters and clams that could be contaminated with norovirus and were sent to nine states, including California, Florida and New York. The shellfish caution covers "certain raw oysters" harvested by Drayton Harbor Oyster Co. and Manila clams harvested by Lummi Indian Business Council from Feb. 13 to March 3, the FDA said in a statement. (Li, 3/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF